Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by NB1017on Mar 29, 2019 11:59am
123 Views
Post# 29554623

RE:RE:RE:Aurora should Indirectly Buy Out Medmen

RE:RE:RE:Aurora should Indirectly Buy Out MedmenI believe that we may see more than one partnership in the form of JV's. With Peltz on board, there will be talks revisited in the beverage industry, and then we will be in the $30/share range. By then the direction of US Cannabis legalization will be more apparent, and then Big Pharma will be stepping up to the plate.
Pinotblanc wrote:
Auctioneer wrote: Why on earth would you wish for Aurora to buy more stuff?  It has bought plenty.  If anything we should be wishing for big pharma to buy out Aurora. 
NB1017 wrote:
Just opening a conversation here, what are your thoughts on Aurora funding a buy out of a US company such as MedMen through Australis or Choom? https://www.cnbc.com/2019/03/28/medmens-financial-troubles-are-a-warning-for-the-marijuana-industry.html




Not now, even with a 100% premium. It is improbable that we would get such a deal, so it is even less interesting. ACB should more than double, I am conservative, but it will take some time. A deal with a beverage company could make the price double as it happened with WEED, and I am not in a hurry to see one. It will take the time it takes for a good deal, not a fast one as many wish. I trust the CEO with the job he made so far, being in so many different sectors. Once ACB is mature enough in some years, I would have to revaluate if it is worth it, depending of the potential of ACB, the div, etc. 


Bullboard Posts